Rk Capital Management buys $26,659,008 stake in MAXIMUS (MMS)

MAXIMUS (MMS) : Rk Capital Management scooped up 35,800 additional shares in MAXIMUS during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 446,400 shares of MAXIMUS which is valued at $26,659,008.MAXIMUS makes up approximately 4.56% of Rk Capital Management’s portfolio.

Other Hedge Funds, Including , Allianz Asset Management Ag sold out all of its stake in MMS during the most recent quarter. The investment firm sold 232,654 shares of MMS which is valued $13,894,097.State Of Wisconsin Investment Board boosted its stake in MMS in the latest quarter, The investment management firm added 39,300 additional shares and now holds a total of 321,252 shares of MAXIMUS which is valued at $19,185,169. MAXIMUS makes up approx 0.07% of State Of Wisconsin Investment Board’s portfolio.Credit Suisse Ag boosted its stake in MMS in the latest quarter, The investment management firm added 23,076 additional shares and now holds a total of 186,302 shares of MAXIMUS which is valued at $11,125,955. MAXIMUS makes up approx 0.01% of Credit Suisse Ag’s portfolio.Glenmede Trust Co Na boosted its stake in MMS in the latest quarter, The investment management firm added 1,974 additional shares and now holds a total of 758,825 shares of MAXIMUS which is valued at $45,036,264. MAXIMUS makes up approx 0.26% of Glenmede Trust Co Na’s portfolio.Gsa Capital Partners Llp reduced its stake in MMS by selling 5,906 shares or 49.61% in the most recent quarter. The Hedge Fund company now holds 6,000 shares of MMS which is valued at $356,100. MAXIMUS makes up approx 0.02% of Gsa Capital Partners Llp’s portfolio.

MAXIMUS closed down -0.01 points or -0.02% at $58.43 with 1,45,444 shares getting traded on Monday. Post opening the session at $58.53, the shares hit an intraday low of $58.28 and an intraday high of $59.02 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, MAXIMUS reported $0.79 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.70. The company had revenue of $617.09 million for the quarter, compared to analysts expectations of $625.08 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

Many Wall Street Analysts have commented on MAXIMUS. Company shares were Reiterated by Maxim Group on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 74 from a previous price target of $71 .KeyBanc Capital Mkts Initiated MAXIMUS on Jul 11, 2016 to “Overweight”, Price Target of the shares are set at $63.

MAXIMUS Inc. provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs such as Medicaid children’s health insurance program (CHIP) health insurance exchanges and other health care reform initiatives Medicare welfare-to-work child support services and other Government programs. It provides health and human services to Governments in the United States Australia Canada the United Kingdom and Saudi Arabia. The Company’s United States federal services business provides various contract vehicles. The Company’s Health Services segment provides a range of business process services as well as related consulting services for state provincial and federal Government programs. The Company’s Human Services segment provides federal national state and county human services agencies with a range of business process services as well as related consulting services.

Leave a Reply

MAXIMUS - Is it time to Sell?

Top Brokerage Firms are advising their investors on MAXIMUS. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.